박찬식 교수
#피부병리#림프망내계병리
|
학력
1996 .03 ~ 1999 .08서울대학교 의학 박사
1989 .03 ~ 1991 .02서울대학교 의학 석사
1983 .03 ~ 1989 .02서울대학교 의학 학사
1989 .03 ~ 1991 .02서울대학교 의학 석사
1983 .03 ~ 1989 .02서울대학교 의학 학사
경력
2012 .04 ~ 현재울산의대 서울아산병원 병리과, 교수
2005 .10 ~ 현재울산의대 서울아산병원 병리과, 부교수
2002 .07 ~ 2005 .09미국 Ochsner Clinic Foundation Research Associate
2000 .09 ~ 2002 .06미국 NIH, NIAID Postdoctoral Fellow
1994 .05 ~ 2000 .02서울대병원 인턴, 레지던트
1991 .03 ~ 1994 .05육군 군의관
2005 .10 ~ 현재울산의대 서울아산병원 병리과, 부교수
2002 .07 ~ 2005 .09미국 Ochsner Clinic Foundation Research Associate
2000 .09 ~ 2002 .06미국 NIH, NIAID Postdoctoral Fellow
1994 .05 ~ 2000 .02서울대병원 인턴, 레지던트
1991 .03 ~ 1994 .05육군 군의관
논문
Cereblon deficiency confers resistance against polymicrobial sepsis by the activation of AMP activated protein kinase and heme-oxygenase-1.
Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).
Reactive oxygen species-induced parthanatos of immunocytes by human cytomegalovirus-associated substance.
Dermatofibrosarcoma Protuberans: An Immunomarker Study of 57 Cases That Included Putative Mesenchymal Stem Cell Markers.
Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
CD99 Is Strongly Expressed in Basal Cells of the Normal Adult Epidermis and Some Subpopulations of Appendages: Comparison with Developing Fetal Skin.
Comparative histopathologic analysis of cutaneous extranodal natural killer/T-cell lymphomas according to their clinical morphology.
Comparative histopathological analysis of cutaneous extranodal natural killer/T-cell lymphomas according to their clinical morphology
Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site
Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.
Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips.
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Prognostic signifiance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
Autophagic Markers BECLIN 1 and LC3 are Associated with Prognosis of Multiple Myeloma.
CD99 regulates CXCL12-induced chemotaxis of human plasma cells.
Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226
Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate Positron Emission Tomography of Inflammatory and Infectious Lesions.
Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.
Indeterminate Dendritic Cell Tumor: A Case Report of a Rare Langerhans Cell Lineage Disease.
Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients.
Regulator of G protein signaling 1 suppresses CXCL12-mediated migration and AKT activation in RPMI 8226 human plasmacytoma cells and plasmablasts.
Secondary cutaneous diffuse large B-cell lymphoma has a higher IPI score and worse prognosis than diffuse large B-cell lymphoma, leg type
Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage
Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
A Case of Type II Enteropathy-Associated T-Cell Lymphoma with Epstein-Barr Virus Positivity.
Abbreviated chemotherapy for limited-stage diffuse large B-cell lymphoma after complete resection.
Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).
Reactive oxygen species-induced parthanatos of immunocytes by human cytomegalovirus-associated substance.
Dermatofibrosarcoma Protuberans: An Immunomarker Study of 57 Cases That Included Putative Mesenchymal Stem Cell Markers.
Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
CD99 Is Strongly Expressed in Basal Cells of the Normal Adult Epidermis and Some Subpopulations of Appendages: Comparison with Developing Fetal Skin.
Comparative histopathologic analysis of cutaneous extranodal natural killer/T-cell lymphomas according to their clinical morphology.
Comparative histopathological analysis of cutaneous extranodal natural killer/T-cell lymphomas according to their clinical morphology
Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site
Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.
Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips.
Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Prognostic signifiance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
Autophagic Markers BECLIN 1 and LC3 are Associated with Prognosis of Multiple Myeloma.
CD99 regulates CXCL12-induced chemotaxis of human plasma cells.
Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226
Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate Positron Emission Tomography of Inflammatory and Infectious Lesions.
Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.
Indeterminate Dendritic Cell Tumor: A Case Report of a Rare Langerhans Cell Lineage Disease.
Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients.
Regulator of G protein signaling 1 suppresses CXCL12-mediated migration and AKT activation in RPMI 8226 human plasmacytoma cells and plasmablasts.
Secondary cutaneous diffuse large B-cell lymphoma has a higher IPI score and worse prognosis than diffuse large B-cell lymphoma, leg type
Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage
Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
A Case of Type II Enteropathy-Associated T-Cell Lymphoma with Epstein-Barr Virus Positivity.
Abbreviated chemotherapy for limited-stage diffuse large B-cell lymphoma after complete resection.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
CXCL12-induced migration of human plasmablasts is dependent on aerobic glycolysis
The Migration of Human Plasmablasts induced by CXCL12 is Dependent Upon Aerobic Glycolysis
Human Plasmablast Migration Towards CXCL12 Requires Glucose Oxidation by Enhanced AKT/PDH Signaling
A validation study of risk stratification models for diffuse large B-cell lymphoma-not otherwise specified in Korean cohort
High glucose concentration impairs CD138+ plasma cell development and immunoglobulin production
Primary follicular lymphoma of the duodenum: a case report
Regulator of G Protein Signaling 1 Suppresses CXCL12-Mediated Migration and AKT Activation in RPMI 8226 Human Plasmacytoma Cells and Plasmablasts
Expression of immune checkpoint molecule VSIG4 is correlated with poor prognosis in multiple myeloma.
A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents.
RGS1 expression in associated with poor prognosis in plasma cell neoplasm
Interim PET-CT as a prognostic tool for predicting clinical outcomes in nodal type T-cell non-Hodgkin lymphoma
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience
A Case of Simultaneous Bone Marrow involvement of Peripheral T cell Lymphoma, NOS in liver and Diffuse Large B cell Lymphoma in stomach
High-dose chemotherapy and autologous stem-cell transplantation for Korean patients with relapsed or refractory Hodgkin lymphoma
The Migration of Human Plasmablasts induced by CXCL12 is Dependent Upon Aerobic Glycolysis
Human Plasmablast Migration Towards CXCL12 Requires Glucose Oxidation by Enhanced AKT/PDH Signaling
A validation study of risk stratification models for diffuse large B-cell lymphoma-not otherwise specified in Korean cohort
High glucose concentration impairs CD138+ plasma cell development and immunoglobulin production
Primary follicular lymphoma of the duodenum: a case report
Regulator of G Protein Signaling 1 Suppresses CXCL12-Mediated Migration and AKT Activation in RPMI 8226 Human Plasmacytoma Cells and Plasmablasts
Expression of immune checkpoint molecule VSIG4 is correlated with poor prognosis in multiple myeloma.
A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents.
RGS1 expression in associated with poor prognosis in plasma cell neoplasm
Interim PET-CT as a prognostic tool for predicting clinical outcomes in nodal type T-cell non-Hodgkin lymphoma
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience
A Case of Simultaneous Bone Marrow involvement of Peripheral T cell Lymphoma, NOS in liver and Diffuse Large B cell Lymphoma in stomach
High-dose chemotherapy and autologous stem-cell transplantation for Korean patients with relapsed or refractory Hodgkin lymphoma
영상자료
영상자료 내용이 없습니다.
발표자료
Microenvironmenntal factors that control human B cell development: ex vivo germinal center recapitulation model
미분화 인체지방조직을 유래 간엽 줄기세포의 이종이식을 이용한 무갑 상선 백서에서의 두개골 결손의 골화 효과
The strong expression of CD99 on human plasma cells, triggering homotypic aggregation
Anti-JL1 immunostaining corroborates the specific diagnosis of leukemia cutis
미분화 인체지방조직을 유래 간엽 줄기세포의 이종이식을 이용한 무갑 상선 백서에서의 두개골 결손의 골화 효과
The strong expression of CD99 on human plasma cells, triggering homotypic aggregation
Anti-JL1 immunostaining corroborates the specific diagnosis of leukemia cutis